Skip to main content
SpringerLink
Log in

Multidisciplinary Approach of Unresectable Head and Neck Cancer

  • Chapter
  • First Online:
Head and Neck Cancer

  • 2476 Accesses

Abstract

The management of locally advanced head and neck cancer has seen the emergence of different combined modality therapies in recent years, and new treatment types, such as chemoradiation, new induction chemotherapy schemes, and salvage surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143–54.

    Article  PubMed  CAS  Google Scholar 

  2. Adelstein DJ, Li Y, Adams GL, Wagner Jr H, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92–8.

    Article  PubMed  Google Scholar 

  3. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–704.

    Article  PubMed  CAS  Google Scholar 

  4. Yousem DM, Hatabu H, Hurst RW, Seigerman HM, Montone KT, Weinstein GS, et al. Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology. 1995;195:715–20.

    PubMed  CAS  Google Scholar 

  5. Yousem DM, Gad K, Tufano RP. Resectability issues with head and neck cancer. AJNR Am J Neuroradiol. 2006;27:2024–36.

    PubMed  CAS  Google Scholar 

  6. Hsu WC, Loevner LA, Karpati R, Ahmed T, Mong A, Battineni ML, et al. Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck. 2005;27:95–100.

    Article  PubMed  Google Scholar 

  7. Haselow R, Warshaw M, Oken M, et al. Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck. In: Fee Jr WE, Goepfert H, Johns ME, et al., editors. Head and neck cancer, vol. II. Philadelphia, PA: Lippincott; 1990. p. 279–81.

    Google Scholar 

  8. Agarwala SS, Cano E, Heron DE, Johnson J, Myers E, Sandulache V, et al. Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol. 2007;18:1224–9.

    Article  PubMed  CAS  Google Scholar 

  9. Sutharalingum M, Haas M, Conley B, Egorin M, Levy S, Sivisailam S, et al. The use of carboplatinum and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Biol Oncol Phys. 2000;47:49–56.

    Article  Google Scholar 

  10. Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, et al. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol. 2006;79:34–8.

    Article  PubMed  CAS  Google Scholar 

  11. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–78.

    Article  PubMed  CAS  Google Scholar 

  12. Langer C, Lee J, Patel U, Shin D, Argiris A, Quon H et al. Preliminary analysis of ECOG 3303: concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 2008;26:(May 20 suppl; abstr 6006).

    Google Scholar 

  13. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949–55.

    PubMed  CAS  Google Scholar 

  14. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–15.

    Article  PubMed  CAS  Google Scholar 

  15. Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2005;23:8636–45.

    Article  PubMed  Google Scholar 

  16. Hitt R, Grau J, Lopez-Pousa A, Berrocal A, Garcia Giron C, Irigoyen A et al. Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU followed by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC). J Clin Oncol 2009;27:15S, (suppl; abstr 6009).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA, 02115, USA

    Robert I. Haddad

Authors
  1. Ricardo Hitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Blanca Homet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert I. Haddad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert I. Haddad .

Editor information

Editors and Affiliations

  1. , Dept of Radio-Oncology, Genolier Swiss Medical Network, 4 Route du Muids, Genolier, CH-1272, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hitt, R., Homet, B., Haddad, R.I. (2011). Multidisciplinary Approach of Unresectable Head and Neck Cancer. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_24

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation